Abstract
In an open-label, multicenter, prospective study, 20 women applied tretinoin (retinoic acid) cream 0.1% daily for 3 months to pregnancy-related stretch marks in the abdominal area. Efficacy was evaluated by analysis of one preselected target lesion, which was rated on a six-point scale (−1 = worse to 4 = cleared). At week 12, significant global improvement was noted from baseline in all stretch marks, and the target lesion decreased in length by 20% (P = .01). Erythema and scaling, the most common adverse events, occurred in 11 patients, decreased in severity after the first month of treatment, and were controlled with continued application of tretinoin and petroleum jelly ointment. In this small study, topical application of tretinoin significantly improved the clinical appearance of pregnancy-related stretch marks.
Similar content being viewed by others
![](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1186%2Fs12884-016-1075-9/MediaObjects/12884_2016_1075_Fig1_HTML.gif)
References
Madlon-Kay DJ. Striae gravidarum: folklore and fact.Arch Fam Med. 1993;2:507–511.
Erickson CV, Matus NR. Skin disorders of pregnancy.Am Fam Physician. 1994;9:605–610.
Hanno R, Saleeby ER, Krull EA. Disorders of pregnancy. In: Dermis DJ, ed.Clinical Dermatology. Philadelphia: Lippincott; 1991:1–5.
Shuster S. The cause of striae distensae.Acta Derm Venereol. 1979;59(suppl 85):161–169.
Pribanich S, Simpson FG, Yarbrough CL, White S. Low-dose tretinoin does not improve striae distensae: a double-blind, placebo-controlled study.Cutis. 1994;54:121–124.
Hecker H. New treatments for stretch marks.Am Baby. 1997;59:6.
Levin W. Striae gravidarum: folklore and fact.Arch Fam Med. 1995;4:98. Letter.
Elson ML. Treatment of striae distensae with topical tretinoin.J Dermatol Surg Oncol. 1990;16: 267–270.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rangel, O., Arias, I., García, E. et al. Topical tretinoin 0.1% for pregnancy-related abdominal striae: An open-label, multicenter, prospective study. Adv Therapy 18, 181–186 (2001). https://doi.org/10.1007/BF02850112
Issue Date:
DOI: https://doi.org/10.1007/BF02850112